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Abstract
 
We report the cloning and functional characterization in the mouse and the rat of a novel nat-
ural killer (NK) cell receptor termed KLRE1. The receptor is a type II transmembrane protein
with a COOH-terminal lectin-like domain, and constitutes a novel KLR family. Rat 
 
Klre1
 
 was
mapped to the NK gene complex. By Northern blot and flow cytometry using newly generated
monoclonal antibodies, KLRE1 was shown to be expressed by NK cells and a subpopulation of
CD3
 
 
 
 cells, with pronounced interstrain variation. Western blot analysis indicated that KLRE1
can be expressed on the NK cell surface as a disulphide-linked dimer. The predicted proteins
do not contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) or a positively
charged amino acid in the transmembrane domain. However, in a redirected lysis assay, the
presence of whole IgG, but not of F(ab
 
 
 
)
 
2
 
 fragments of a monoclonal anti-KLRE1 antibody in-
hibited lysis of Fc-receptor bearing tumor target cells. Moreover, the tyrosine phosphatase
SHP-1 was coimmunoprecipitated with KLRE1 from pervanadate-treated interleukin 2–acti-
vated NK cells. Together, our results indicate that KLRE1 may form a functional heterodimer
with an as yet unidentified ITIM-bearing partner that recruits SHP-1 to generate an inhibitory
receptor complex.
Key words: natural immunity • lymphocytes • immunological receptors • molecular sequence 
data • protein-tyrosine-phosphatase
 
Introduction
 
NK cells have the capacity to specifically recognize and kill
certain tumor cells, virally infected cells and MHC-dispar-
ate normal hematopoietic cells (1–3). The target cell recog-
nition depends upon an interplay between activating and
inhibitory membrane receptors (4), recognizing a number
of different ligands including MHC class I or class I–like
molecules (5–7). The receptors belong to two different
protein families, the killer cell lectin-like receptors (KLRs)
 
*
 
and receptors with immunoglobulin-like domains. Promi-
nent among the latter are the killer cell immunoglobulin-
like receptors (KIRs). Both contain inhibitory as well as
activating members (8–10). As a rule, the inhibitory recep-
tors have cytoplasmic tails with immunoreceptor tyrosine-
based inhibitory motifs (ITIMs), with the consensus se-
quence I/V/L/SxYxxV/L (11).The activating receptors
lack ITIM, but instead have a positively charged amino
acid in the transmembrane (TM) domain, mediating associ-
ation with adaptor molecules containing immunoreceptor
tyrosine-based activating motifs (ITAM). After receptor
engagement, tyrosine residues are phosphorylated, where-
upon the ITIM and the ITAM recruit SH2 domain-con-
taining tyrosine phosphatases and -kinases, respectively (4,
10–16). In particular, the protein tyrosine phosphatase
SHP-1 has been demonstrated to associate with phos-
phorylated ITIMs, and to mediate inhibition of NK cell
cytotoxicity (11–16). The KLRs are encoded by a distinct
chromosomal region, the NK cell gene complex (NKC),
which maps to homologous regions on mouse chromosome
6 (17), rat chromosome 4 (18), and human chromosome
12p13 (19). Several different NKC-encoded KLR families
have so far been identified, typically expressed as homo- or
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Abbreviations used in this paper:
 
 ITIM, immunoreceptor tyrosine-based
inhibitory motif; KLR, killer cell lectin-like receptor; NKC, NK cell
gene complex; ORF, open reading frame; PFGE, pulsed field gel electro-
phoresis; TM, transmembrane.T
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heterodimers. The inhibitory members of the Ly-49 family
are homodimers with one ITIM per molecule, yielding
two ITIMs in close proximity. In contrast, the inhibitory
heterodimer CD94/NKG2A recruits SHP-1 via the two
ITIMs located in tandem within the cytoplasmic tail of one
of the chains (NKG2A), whereas no direct signaling func-
tion has been described for the CD94 chain (20–22).
Here, we have cloned and characterized in the mouse
and the rat a novel NK cell receptor termed KLRE1. The
predicted proteins do not contain an ITIM in the cytoplas-
mic tail or a charged amino acid in the TM domain. We
present evidence that despite the lack of ITIMs, KLRE1
forms part of an inhibitory receptor able to recruit the tyro-
sine phosphatase SHP-1.
 
Materials and Methods
 
Animals.
 
The inbred rat strains PVG, AUG, DA, AO,
AGUS, LEW, DA.NKC
 
b/b
 
, and DA 
 
 
 
 (DA 
 
 
 
 PVG)F
 
1
 
 hybrids
were reared under conventional conditions (routinely screened
for pathogens) in Oslo, or obtained commercially (Harlan Olac).
DA 
 
 
 
 (DA 
 
 
 
 PVG)F
 
1
 
 rats were generated from breeding pairs
of male (DA 
 
 
 
 PVG)F
 
1
 
 and female DA rats. The NKC congenic
rat strain DA.NKC
 
b/b
 
 was generated by backcrossing (DA 
 
 
 
PVG)F
 
1
 
 to DA for ten generations (selecting male offspring het-
erozygous at the NKC (NKC
 
a/b
 
) by RFLP analysis of the 
 
Nkrp1b
 
locus) followed by inbreeding. The experimental protocol was
approved by the institute veterinary surgeon and registered by
the Experimental Animal Board under the Ministry of Agricul-
ture of Norway. Inbred mice were purchased from The Jackson
Laboratory.
 
Cloning of Mouse and Rat KLRE1 cDNA.
 
COS-7 cells were
transfected by DEAE-dextran with a cDNA library prepared
from IL-2 activated polyclonal mouse NK cells derived from
CB.17 SCID mice in the pME18S vector (generously provided
by Dr. Vinay Kumar, University of Texas, Dallas, Texas). After
72 h, the transfected COS-7 cells were stained with PE-conju-
gated DX6 mAb and the antigen-positive cells were isolated by
fluorescence-activated cell sorting (Becton Dickinson). Antigen-
positive cells were lysed in Hirt solution and plasmids were re-
covered by bacterial transformation. After three rounds of selec-
tion using transfected COS-7, individual plasmids were isolated
and analyzed by transfection for DX6 antigen expression (23). A
single plasmid was selected and confirmed to encode a protein re-
active with the DX6 antibody.
The open reading frame (ORF) of the mouse DX6 antigen
cDNA was used as a probe to screen a cDNA library made from
IL-2 activated NK cells from F344 rats (provided by Dr. James C.
Ryan, University of California, San Francisco, CA; reference 18).
2 
 
 
 
 10
 
6
 
 plaques were lifted onto nylon membranes (Colony/
Plaque Screen, NEN Life Science Products) and hybridized to ra-
diolabeled probe (Megaprime DNA labeling system; Amersham
Biosciences) under low stringency conditions, as described earlier
(24). 10 independent clones were isolated and sequenced. Nested
PCR was performed on genomic DNA extracted from DA and
F344 liver cells (outer primer pair: 5
 
 
 
-TGCTATGAGGCTGT-
GAAGTGTGTT-3
 
 
 
 versus 5
 
 
 
-ATGTTTTTGGTATTTTTGC-
CTCTGCT-3
 
 
 
; inner primer pair: 5
 
 
 
-ACCCTGCTCCCAGT-
TCTGTCTTA-3
 
 
 
 versus 5
 
 
 
-TTGCCTCTGCTCAATGGAT-
GACAAT-3
 
 
 
). To obtain cDNA corresponding to the two splice
variants, forward primers made on the basis of genomic sequences
(5
 
 
 
-CAGAATTTTTGTCTTTATA-3
 
 
 
 [rKLRE1 long] or 5
 
 
 
-
CCTCCTTGCTTCAGAAGAGCAAA-3
 
 
 
 [rKLRE1 short]) were
used together with a 3
 
 
 
UTR specific reverse primer (5
 
 
 
-ACC-
AAAAATTAAGACTTTA-3
 
 
 
) in reverse transcriptase PCR us-
ing total RNA from IL-2 activated DA NK cells (25). The PCR
products were cloned into the pCR2.1-TOPO plasmid vector
(Invitrogen), and three individual clones were completely se-
quenced on both strands as detailed previously (24).
 
Cell Preparations.
 
NK cells were purified from rat spleen by
Isopaque-Ficoll density centrifugation (Lymphoprep; Nycomed)
followed by passage through nylon wool (Leucopac; Fenwal Lab-
oratories) and removal of T cells and B cells by negative selection
with anti-CD3 mAb G4.18 (26), anti-TCR
 
 
 
/
 
 
 
 mAb R73 (27),
anti-CD5 mAb OX19 (28), anti-MHC class II mAb MRC OX6
(29), and immunomagnetic beads coated with sheep anti–mouse
IgG (Dynal). Remaining cells were incubated at 37
 
 
 
C for 11 d in
complete medium (RPMI 1640 [GIBCO BRL] containing 1
mM sodium pyruvate, 2 mM 
 
l
 
-glutamine, 1% standard antibi-
otic/antimycotic solution and 10% FCS [GIBCO BRL]). 5 
 
 
 
10
 
5 
 
M 2-ME and rat rIL-2 (30) equivalent to 1,000 IU/ml of hu-
man IL-2 was added, yielding a 
 
 
 
98% NKR-P1
 
 
 
 NK cell popu-
lation as determined by flow cytometry using mAb 3.2.3 (31).
Thoracic duct CD4
 
 
 
 T cells (
 
 
 
95% W3/25
 
 
 
 [32] by flow cy-
tometry), CD8
 
 
 
 T cells (
 
 
 
91% OX8
 
 
 
 [33] by flow cytometry),
and B cells were purified as described (24). The macrophage cell
line R2
 
 
 
(34) and the mast cell line RBL-2H3 (35), and the F344-
derived NK cell lines RNK-16 (36) and A181 (37) were cultured
under standard conditions in complete medium. 2-ME was added
to the NK cell medium. A stable, IL-2–dependent rat NK cell
line termed RNK
 
DA1
 
 was generated from DA rat spleen NK cells
by long term culture in complete medium with IL-2 and 2-ME
as above. The cells were analyzed by flow cytometry and shown
to be NKR-P1
 
 
 
/CD3
 
 
 
.
 
Southern and Northern Blot Analysis.
 
DNA was extracted
from rat liver, digested with restriction endonucleases (New
England Biolabs, Inc.), subjected to horizontal agarose gel elec-
trophoresis, and blotted onto nylon membranes (Biotrans mem-
branes; ICN Biomedicals) by conventional methods. Extraction
of total cellular RNA, formaldehyde agarose gel electrophoresis,
and transfer to nylon membranes was performed by conven-
tional methods. Equal loading of RNA in all lanes was verified
by ethidium bromide staining. Hybridization was performed
under conditions described earlier (18). All probes were radiola-
beled with [
 
32
 
P] dCTP (Megaprime DNA labeling system; Am-
ersham Biosciences).
 
Pulsed Field Gel Eectrophoresis.
 
Pulsed field gel electrophore-
sis (PFGE) was performed by standard methods, using single-cell
suspensions from PVG lymph nodes embedded in agarose plugs.
Horizontal agarose gels were run in a Rothaphor R22 electro-
phoresis chamber (Biometra), with microprocessor-controlled
cooling, and ramping of voltage, switch time, and field angle.
DNA was transferred to nylon membrane by exposing the gel to
302 nm UV light for 45 s, denaturing in 0.5 M NaOH, 1.5 M
NaCl, neutralizing in 3 M sodium acetate pH 5.5, followed by
capillary transfer in 20
 
  
 
SSC buffer for 24 h, and hybridized un-
der conditions as described (18).
 
Transfections.
 
An expression construct of the short rat KLRE1
was generated as follows: Kozak sequence and ORF of KLRE1
(excluding stop codon) was amplified by PCR using gene spe-
cific primers containing XhoI and SalI restriction sites, respec-
tively (5
 
 
 
-CTCGAGCCGATCCTGGAATTTCCTCCTT-3
 
 
 
/5
 
 
 
-
GTCGACCTTCTTGCAAATGTACATTAGT-3
 
 
 
). The PCR
product was cloned into pCR2.1-TOPO (Invitrogen) and theT
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XhoI/SalI fragment inserted into pECHA (a bicistronic, stable
expression vector with SR
 
 
 
 promotor upstream of a cloning site
followed by a HA tag sequence and a stop codon, and finally a ri-
bosomal reentry site (IRES) from EMCV followed by the Neo
resistance gene [unpublished data]). The resulting ORF con-
tained the full KLRE1 with the amino acid sequence VDYP-
YDVPDYA added at the COOH terminus. 293T cells were
transfected with the KLRE1-HA expression construct using Li-
pofectamine (GIBCO BRL): 10 
 
 
 
g plasmid DNA was prein-
cubated with 60 
 
 
 
l lipofectamine for 15 min at room tempera-
ture in 1.4 ml OPTI-MEM (GIBCO BRL), mixed with 5.6 ml
OPTI-MEM, and added to 20 
 
  
 
10
 
6
 
 293T cells in a 75 cm
 
2
 
 flask.
After incubation for 5–6 h at 37
 
 
 
C, 7 ml of RPMI 1640/20%
FCS was added, and the cells were further cultured at 37
 
 
 
C for
19 h. The transfection mixture was poured off, and the cells de-
tached with 0.5 mM EDTA in PBS. Successful transfection was
verified by flow cytometry analysis for surface staining with anti-
HA and -KLRE1 antibodies. To stably transfect RNK
 
DA1
 
 cells
with the KLRE1-HA expression construct, 3 
 
 
 
 10
 
6
 
 cells in 0.4
ml complete medium with 2-ME and IL-2 were mixed with 20
 
 
 
g linearized plasmid DNA at 4
 
 
 
C in a 2 mm cuvette and elec-
troporated at 120 V, 960 uF (Gene-Pulser; Bio-Rad Laborato-
ries). Stably transfected cell clones were selected by culture in 2
mg/ml geneticin (G-418 disulphate; Duchefa) and tested for sur-
face expression of KLRE1-HA by flow cytometry with WEN27
and anti-HA mAbs.
 
Biochemistry.
 
DA NK cell and RNK
 
DA1
 
 cell membrane pro-
teins were prepared by lysing cells in 1% Triton X-114 as de-
scribed (38). The membrane protein fractions were analyzed on
SDS-PAGE, transferred to PVDF membrane (Immobilon P; Mil-
lipore) and probed with 20 
 
 
 
g/ml WEN27 mAb, 1 
 
 
 
g/ml
HA.11 mAb (MMS-101R; Covance), or 1 
 
 
 
g/ml rabbit anti-
mouse SHP-1 antiserum (C-19; Santa Cruz Biotechnology, Inc.)
followed by goat anti–mouse IgG HRP or goat anti–rabbit IgG
HRP (Jackson ImmunoResearch Laboratories) and chemilumi-
nescent detection (Super Signal Substrate system; Pierce Chemical
Co./BioMaxMR film; Eastman Kodak Co.). For immunoprecip-
itations, cells were lysed in 1% digitonin buffer (25 mM Tris-HCl,
150 mM NaCl, pH 7.5, 1% digitonin, 1 mM NaF, 1 mM PMSF,
1 mM Na
 
3
 
Vo
 
4
 
, 10 
 
 
 
g/ml leupeptin, and 10 
 
 
 
g/ml aprotinin) for
30 min at 4
 
 
 
C, then centrifuged 15 min at 16,000 
 
g
 
 in a micro-
centrifuge. The supernatant was collected, and precleared for 1 h
with 20 
 
 
 
l protein A/G beads (Santa Cruz Biotechnology, Inc.),
then centrifuged for 2 min at 2,300 
 
g
 
. The supernatant was col-
lected and added specific antibody (6 
 
 
 
g rabbit anti–mouse SHP-1
antiserum or 3 
 
 
 
g rabbit HA probe [C-19 and Y-11, respectively;
Santa Cruz Biotechnology, Inc.]) and incubated o/n at 4
 
 
 
C. 30 
 
 
 
l
protein A/G beads (Santa Cruz Biotechnology, Inc.) were added
and precipitation performed for 2 h at 4
 
 
 
C. The beads were
washed three times with 0.5% digitonin lysis buffer and centrifu-
gation for 3 min at 2,300 
 
g
 
, resuspended in SDS sample buffer, and
boiled for 2 min. Samples were run on SDS-PAGE, transferred to
PVDF membranes, and analyzed as described above. For sodium
pervanadate stimulation, 100 
 
 
 
 10
 
6
 
 cells in 0.5 ml PBS were pre-
incubated at 37
 
 
 
C for 5 min, then added 5 
 
 
 
l of a 100
 
 
 
 sodium
pervanadate solution to 0.01% H
 
2
 
O
 
2
 
, 100 
 
 
 
M Na
 
3
 
VO
 
4
 
, and incu-
bated for 5 min at 37
 
 
 
C. The stimulation was stopped by adding
ice cold 2   1% digitonin lysis buffer, and the cells were lysed for
30 min at 4 C as described above.
Generation of Anti-mKLRE1 mAb DX6, Anti-rKLRE1 mAb
WEN27, and WEN27 F(ab )2 Fragments. Spleen cells from out-
bred Lewis rats immunized with NK cells isolated from C57BL/6
mice were fused with the mouse SP2/0 myeloma cell line by
conventional techniques. The DX6 hybridoma was selected by
flow cytometry for mAbs reactive with splenic NK cells from
C57BL/6 mice. The anti-rKLRE1 mAb WEN27 was obtained
by immunization of BALB/c female mice with a soluble
KLRE1/hFc 1 fusion protein. This fusion protein was produced
in 293T cells transiently transfected (Lipofectamine, see above)
with an expression construct consisting of the human CD8  sig-
nal peptide coupled in-frame to the hinge, CH2 and CH3 re-
gions of human IgG1, again coupled in-frame at its COOH-ter-
minal end to the extracellular region of rKLRE1. WEN27
F(ab )2 fragments were produced by digestion of the WEN27
mAb with 0.1 mg/ml pepsin (P7012; Sigma-Aldrich) in 0.2 M
Na acetate buffer pH 4.0 for 3 h at 37 C. Digested immunoglob-
ulin was dialyzed into PBS pH 8.0 after pepsin digestion, and in-
tegrity of the F(ab )2 fragments was confirmed by gel electro-
phoresis and flow cytometry.
Flow Cytometry. For single-color analysis, 50  l of cells (107
cells/ml) were incubated with 50  l of Ab for 30 min on ice
(anti-rKLRE1 mAb WEN27, anti-mKLRE1 mAb DX6, and
anti-HA mAb HA.11). After three washes, labeled cells were
incubated with F(ab )2 of FITC conjugated sheep anti–mouse
or goat anti–rat Ig (Sigma-Aldrich). For two-color analysis of rat
cells from 2-mo-old individuals, mesenterial lymph nodes were
disrupted in PBS and filtered (CellStrainer; Becton Dickinson).
Spleen cells were obtained by density centrifugation (Lympho-
prep; Nycomed) followed by passage through nylon wool
(Leucopac; Fenwal Laboratories). Primary labeling was with
WEN27, followed by FITC conjugated F(ab )2 of sheep anti–
mouse IgG (F-2266; Sigma-Aldrich), mouse IgG, and either
PE-conjugated anti-CD3 (PE-G4.18; BD Biosciences), biotin-
labeled anti-Ig kappa light chain (OX12 [39]), or biotin-labeled
anti-NKR-P1 (3.2.3 [31]). Biotinylated mAbs were detected
using PE-conjugated streptavidin (Jackson ImmunoResearch
Laboratories). C57BL/6 spleen cells were analyzed using PE-
anti-NK1.1, PE-DX5 (40), PE-anti-CD19, Cychrome-anti-
CD3, biotin-labeled DX6, and PE-and biotin-labeled isotype
control antibodies (BD Biosciences). Biotin-labeled antibodies
were detected using Alexa-488 conjugated streptavidin (Molec-
ular Probes). Stained cells were analyzed by flow cytometry
(FACScan™; Becton Dickinson).
Redirected Lysis Assay. Standard 4 h in vitro cytotoxicity as-
says were performed as described (41). Exponentially growing
YAC-1, P388D1, and P815 cells were harvested and labeled for
1 h at 37 C with 100  Ci 51CrNa2O4. Labeled target cells were
washed and resuspended at 105 cells/ml and 100  l of this cell
suspension was added to each assay well. IL-2–stimulated DA NK
effector cells were harvested and resuspended in growth medium
at densities indicated in the figure legends. 15-min preincubations
with WEN27, WEN27 F(ab )2, and control IgG were performed
where indicated. 100  l of effector cells were added to each assay
well. Plates were centrifuged for 1 min at 130 g and incubated at
37 C for 4 h. The supernatant was harvested and counted in a
gamma counter. The results are presented as median values from
triplicates for each effector/target cell ratio. Spontaneous release
of 51Cr was less than 10%.
Results
Cloning of Mouse and Rat KLRE1. A rat monoclonal
antibody toward mouse NK cells, named DX6, was ob-
tained by immunizing rats with mouse NK cells, and se-
lecting by flow cytometry for mAbs reactive with splenicT
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NK cells from C57BL/6 mice. A mouse cDNA clone en-
coding the DX6 antigen was isolated by expression clon-
ing, using COS-7 cells transfected with a cDNA expression
library prepared from IL-2–stimulated polyclonal mouse
NK cells derived from CB.17 SCID mice. The transfected
cells were stained with DX6 and the antigen positive cells
isolated by cell sorting. After three rounds of selection, in-
dividual plasmids were isolated and analyzed for DX6 anti-
gen expression after transfection. A single plasmid was se-
lected for sequence analysis, and contained a cDNA insert
of 1324 nucleotides, with an ORF predicting a polypeptide
of 226 amino acids, with a relative molecular mass of 26.2
kD and two potential sites for N-linked glycosylation
(GenBank/EMBL/DDBJ accession no. AY100458).
Using the ORF fragment of the mouse cDNA clone to
screen an F344 rat NK cell cDNA library, a rat cDNA
clone of 940 nucleotides was isolated, containing an ORF
of 202 amino acids, 82.2/88.3% identical to the mouse
clone at the amino acid/nucleotide levels (GenBank/
EMBL/DDBJ accession no. AF86187). Five additional rat
clones were completely or partially sequenced, all appar-
ently identical. No additional clones were obtained by re-
hybridizing the filters with a rat probe. The predicted
mouse and rat polypeptides are type II integral membrane
proteins with a COOH-terminal C-type lectin-like do-
main (Fig. 1 A). Sequence comparisons showed that they
belong to the KLRs, but constitute the first members of a
separate, novel family (family E) and have thus been termed
mouse and rat KLRE1 (Fig. 1 B).
Compared with mKLRE1, the cloned rKLRE1 cDNA
lacked 70 nucleotides, including the mKLRE1 start codon,
predicting a protein with a shorter cytoplasmic domain.
Genomic sequencing of rat liver DNA revealed an intron
at position –24 relative to the rKLRE1 start codon. The
3 -terminal part of the intron showed high sequence simi-
larity with the missing 70 nucleotides and with a consensus
3  splice site immediately upstream, suggesting the possibil-
ity of alternative splicing. A new set of clones was obtained
Figure 1. (A) Alignment of the amino acid sequences of rat and mouse
KLRE1. Identical amino acids are indicated by dashes, and the transmembrane
region of the KLRE1 polypeptide has been underlined. Cysteines forming intra-
chain disulphide bridges are marked with asterisks, and a free cysteine possibly in-
volved in interchain bonding is marked with a diamond. No ITIM motif is
present in the cytoplasmic tails, and no charged amino acid in the transmembrane
domains. The five intron sites within the coding region are marked with dots
(with phases 1, 1, 1, 0, and 2, in that order). (B) Dendrogram displaying total
amino acid identity among members of the different KLR families yet identified.
Rat and mouse KLRE1 constitute a separate branch of the KLRs, most closely
related to CD94. The GenBank/EMBL/DDBJ accession nos. of the analyzed se-
quences are: M25812, U10304 (mLy-49A and B, respectively), U56863,
U56822, (rLy-49.9 and 0.12, respectively), AF416564 (rKLRH1), AF350409,
AF350410 (mCLR-B and -F, respectively), AF321552 (rOCIL), X96719 (hAICL),
L23638 (mCD69), NM010652, NM010653 (mNKG2A and C, respectively),
AF021350, AF021349 (rNKG2A and C, respectively), AF030313 (mNKG2D),
AF009511 (rNKR-P2), AY100458 (mKLRE1), AF486186 (rKLRE1),
AF030311 (mCD94), AF009133 (rCD94), AF200949 (hCLEC1), AF201457
(mCLEC2), AJ010751, X79812 (mouse and rat MAFA, respectively), M62891,
U56936 (rNKR-P1A and B, respectively), M77676, M77677 (mNKR-P1A and
B, respectively), AF139769 (mMDL1), and NM016523 (hKLRF1).T
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by RT-PCR of mRNA from IL-2 stimulated DA NK cells
with a 3 -UTR–specific reverse primer and a 5 -UTR–
specific forward primer spanning the expected alternative
splice site. Three individual clones were sequenced. The
760 nt consensus sequence contained an ORF of 226
amino acids, similar in length to mKLRE1, showing 80.5/
87.8% identity at the amino acid/nucleotide levels (Gen-
Bank/EMBL/DDBJ accession no. AF486186; Fig. 1 A).
The presence of a short KLRE1 variant in DA NK cells,
identical to the F344 KLRE1, was confirmed by cloning
using a 5  forward primer specific for the short rKLRE1,
followed by sequence analysis of three individual RT-PCR
clones (GenBank/EMBL/DDBJ accession no. AF86185).
Southern blot analysis of rat genomic DNA digested
with different restriction enzymes showed a single band
when hybridized to a probe derived from the middle exon
of the lectin-like domain, indicating a single gene without
close relatives (unpublished data). The short and long
rKLRE1 sequences are therefore not products of separate
genes, but result from alternative splicing of a 5 UTR in-
tron, where a single donor site is spliced to two different
acceptor sites. In the rat, the two splice sites are each fol-
lowed by in-frame start codons. In the mouse, however,
only the first of the corresponding two codons was ATG,
whereas the second was ATT (isoleucine). Searching the
NCBI rat Trace archive using the rat KLRE1 sequence
yielded 19 genomic trace sequences covering all six trans-
lated exons. The deduced intron sites and phases were typ-
ical for KLR genes (Fig. 1 A). rKLRE1 has two putative
sites for N-linked glycosylation, and the unglycosylated
forms have a predicted relative molecular mass of 23.6
(short) and 26.2 (long) kD, respectively. The cytoplasmic
domains of both mouse and rat KLRE1 lack ITIMs, and
the transmembrane domains do not contain charged amino
acids (Fig. 1 A).
The Klre1 Locus Maps to the NK Cell Gene Complex.
Southern blot analysis of rat and mouse genomic DNA was
consistent with a single KLRE1 gene. Southern blot of
liver DNA from PVG and DA rats digested with BstXI,
gave different restriction patterns when hybridized to a full-
length KLRE1 probe. This polymorphism was used to
analyze a panel of 223 DA   (PVG   DA)F1 rats pre-
viously involved in mapping of several other KLR genes.
The Cd94, Nkrp2, and Nkg2 genes have previously been
mapped to the middle part of the NKC, flanked proximally
by the Nkrp1 and distally by the Ly-49 gene clusters (18,
24–25, 42). Klre1 was found to cosegregate with Nkrp1b,
Cd94, Nkrp2, Nkg2, Klrh1 (43) and proximal Ly49 genes
in all 223 rats, thus mapping the Klre1 locus to the NKC
on rat chromosome 4. For more precise mapping, genomic
PFGE analysis was performed. The full-length KLRE1
probe hybridized to a Pme I fragment of  115 kb contain-
ing the members of the Nkg2 gene family, the Nkrp2 and
Cd94 loci. The mapping was confirmed by data recently
released by the Rat Genome Sequencing Consortium
(www.ncbi.nlm.nih.gov/genome/guide/rat) where the rat
KLRE1 sequence was positioned immediately proximal to
rat CD94 (distance  12 kb). Analysis of the genomic se-
quence released by the Mouse Genome Sequencing Con-
sortium (www.ncbi.nlm.nih.gov/genome/guide/mouse),
showed conservation of localization, orientation, and dis-
tance to CD94, with the mKLRE1 sequence located  15
kb proximal to mouse CD94 in the middle part of the
mouse NKC on chromosome 6.
KLRE1 Is Expressed by NK Cells and a Subset of CD3 
Cells. In the rat, Northern blot analysis using the full-
length rat KLRE1 probe showed KLRE1 transcripts in IL-
2–activated DA NK cells and the NK cell lines RNK16
and A181, but not in T cells, B cells, the macrophage cell
line R2 or the mast cell line RBL-2H3 (Fig. 2 A). To in-
vestigate surface level expression, a monoclonal antibody
toward rKLRE1, termed WEN27 (Fig. 2 B) was generated
by immunizing mice with a soluble fusion protein of the
extracellular region of rKLRE1 coupled to the Fc region of
human IgG1. Flow cytometry with WEN27 showed that
all NKR-P1bright spleen cells in DA rats expressed KLRE1.
A small population ( 1.5%) of the CD3  cells from spleen
showed weak KLRE1 expression, whereas all CD3  cells
from lymph node were KLRE1 . B cells from lymph node
or spleen (Ig kappa light chain positive) did not express
KLRE1 (Fig. 2 C). Similarly, flow cytometry analysis of
mouse spleen cells with the anti-KLRE1 antibody DX6
showed that mKLRE1 was expressed by most NK cells
(stained by either DX5 or NK1.1), and in addition by a
subset of the CD3  cells (Fig. 2, D and E). The fraction of
NK cells that was stained with KLRE1 was strain depen-
dent (see below).
KLRE1 Expression Varies Between Strains of Mice and
Rats. In the mouse, KLRE1 expression levels were tested
by triple staining flow cytometry on DX5 positive cells
from 24 different inbred strains. NK cells from all the
strains expressed KLRE1, although mostly at low levels
(KLRE-1dim cells; Table I). Only five of the strains, SWR/J
(H-2a), MA/MyJ, C58/J, and C3H/HEN (H-2k) and SJL/J
(H-2s) harbored KLRE1bright cells. In seven of the strains
tested only fractions of the NK cells were stained by DX6.
In the remaining strains, all NK cells were KLRE1  (Table
I). All the strains tested bearing the H-2b and H-2d haplo-
types were KLRE1dim. However, NK cells from only one
of three strains with the H-2a haplotype and three of eleven
with the H-2k haplotypes exhibited strong KLRE1 expres-
sion (Table I). The data therefore do not provide sufficient
evidence to suggest MHC-induced down-regulation of
KLRE1 expression in H-2b and H-2d haplotypes.
Strain-dependent KLRE1 expression was also demon-
strated in the rat, where Northern blot analysis of IL-2 acti-
vated NK cells demonstrated markedly higher levels of
transcription in NK cells from AGUS, LEW and DA rats
than from PVG, AO and AUG rats (Fig. 3 A). Flow cy-
tometry analysis of KLRE1 surface expression on NK cells
stimulated with IL-2 for 14 d showed bright staining of all
DA NK cells, but hardly detectable staining of PVG NK
cells. KLRE1 was not expressed on NK cells from the
MHC congenic rat strain PVG.1AV1, or on NK cells from
a congenic DA rat strain carrying the NKC of the PVG
haplotype (DA.NKCb/b), indicating that the difference inT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
1556 KLRE1 Inhibits NK Cell Cytotoxicity
expression levels between these two particular strains is not
controlled by the MHC, but by factors intrinsic to the
NKC (Fig. 3 B). By Southern blot analysis, the PVG allele
of Klre1 did not appear to contain large deletions (unpub-
lished data). The difference in expression between these
two strains applied both to freshly isolated and IL-2 stimu-
lated NK cells (unpublished data).
KLRE1 Can Be Expressed As a Disulphide-linked Dimer.
A rat NK cell line termed RNKDA1 was generated by isola-
tion of NK cells from the spleen of DA rats. The NK cells
were kept growing in media containing IL-2 and shown by
flow cytometry to be NKR-P1 /CD3 . The RNKDA1 cell
line was stably transfected with a rKLRE1-HA tag expres-
sion construct (Fig. 4 A) and Western blot analyses per-
formed on cell lysates of these cells as well as of 293T cells
transiently transfected with the same expression construct.
Using anti-HA antibodies or the WEN27 mAb a  54 kD
band was found under nonreducing conditions and a  27
kD band under reducing conditions, demonstrating that af-
ter transfection KLRE1 formed disulphide linked dimers
(Fig. 4, B–D). Unexpectedly, in IL-2–stimulated DA NK
cells and in the nontransfected RNKDA1 cell line (unpub-
lished data), the 27 kD band, probably corresponding to a
monomeric form of KLRE1, was more prominent than the
 54 kD band under nonreducing conditions (Fig. 4 E).
KLRE1 Inhibits NK Cell Cytotoxicity. The functional
activity of KLRE1 was assessed by a redirected lysis assay,
using IL-2–stimulated DA NK cells as effector cells and the
Figure 2. KLRE1 is expressed by NK cells and a subset of T cells. (A) Northern blot
analysis of total RNA from different cell types, hybridized to a full-length KLRE1 probe.
A181 and RNK16 are rat NK cell lines, R2 is a rat macrophage line, and RBL-2H3 is a rat
mast cell line. (B) The newly generated mAb WEN27 specifically recognizes rKLRE1,
demonstrated by flow cytometry analysis of 293T cells transfected with empty vector or
with a rKLRE1 expression construct. Staining of transfected cells with secondary antibody
(sheep anti–mouse) alone is shown for comparison. (C) Flow cytometry analysis of double
stained lymph node cells and spleen cells from DA rats with anti-KLRE1 mAb WEN27, and
mAbs specific for rat CD3, Ig kappa light chain and NKR-P1. (D) The DX6 mAb specifi-
cally recognizes mKLRE1. Surface expression of a mKLRE1 expression construct in trans-
fected 293T cells. Thin line: empty vector/DX6, dotted line: mKLRE1/goat anti–rat-
FITC, thick line: mKLRE1/DX6. (E) Flow cytometry analysis of mouse spleen cells with
the anti-mKLRE1 monoclonal antibody DX6. C57BL/6 spleen (adult) was stained with
PE-anti-NKR-P1, PE-DX5, PE-anti-CD19, Cychrome-anti-CD3, biotin-labeled DX6,
and PE-and biotin-labeled isotype control antibodies.T
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Fc-receptor bearing (FcR ) tumor cell-lines P388D1 and
P815 and the FcR  line YAC-1 as targets. In the absence
of WEN27 antibody, all target cell types were efficiently
lysed. Killing of the FcR  targets was inhibited when the
effector cells had been preincubated with WEN27 anti-
body (whole IgG molecules). Incubation with WEN27
F(ab )2 fragments did not affect killing, demonstrating that
the inhibition observed with intact mAb was not a result
of blocking of an activating receptor. Treatment with
WEN27 mAb did not influence lysis of YAC-1 cells. Pre-
treating the effector cells with an isotype matched mAb had
no effect on the level of cytotoxicity against P815 and
P388D1, whereas pretreatment with an antibody against
the activating receptor NKp46 augmented killing (Berg,
S.F., I.H. Westgaard, personal communication). The re-
sults show that cross-linking of KLRE1 inhibits NK cell
mediated cytotoxicity (Fig. 5).
KLRE1 in Dimeric Form Associates with SHP-1. As a
rule, the inhibitory NK receptors transmit their signals via
protein tyrosine phosphatases, in particular SHP-1, docking
to the phosphorylated ITIMs after receptor engagement
(11–16, 21). To examine whether SHP-1 plays a role in
signal transduction via KLRE1, cells from the KLRE1-HA
transfected, IL-2–dependent DA NK cell line (RNKDA1-
tx) were pretreated with pervanadate, and digitonin lysates
of the cells were precipitated with anti-HA or anti-SHP-1
antibodies. By Western blotting, anti-SHP-1 was found to
precipitate KLRE1 and vice versa (Fig. 6, A and B).
Whereas the most prominent band detected on Western
blots from nontransfected DA NK cells was  27 kD, the
major anti-KLRE1 immunoreactivity following immuno-
precipitation with anti-SHP-1 was found at a  54 kD
Table I. KLRE1 Expression in Inbred Mouse Strains
H-2 haplotypes
KLRE1a a b d k z/s/v
Bright Ma/MyJ 100
C58/J 50
SWR/J 75b C3H/HEN 75 (s) SJL/J 50
Dim CE/J 75
C57BR/cdJ 100
ST/bj 100
AKR/J 50
C57BL/6J 100 C3H/HeJ 100
C57BL/10J 100 NZB/BINJ 25 C3HeB/FeJ 100
A/J 100 C57L/J 100 BALB/c 100 CBA/CaJ 100 (z) NZW/LacJ 100
DBA/1J 100 LP/J 100 DBA-2J 100 CBA/J 100 (v) SM/J 100
The table shows flow cytometric analyses of KLRE1 expression levels in DX5-positive spleen cells from 24 different inbred mouse strains, grouped
according to H-2 haplotypes.
aKLRE1 staining intensity.
bPercentage of KLRE1-positive NK.
Figure 3. KLRE1 expression is strain dependent. (A) Northern blot
analysis of total RNA from IL-2 activated NK cells from different inbred
rat strains, hybridized to a full length KLRE1 probe. (B) Flow cytometry
analysis of double stained spleen cells from the DA, PVG, PVG.1AV1,
and DA.NKCb/b rat strains.T
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1558 KLRE1 Inhibits NK Cell Cytotoxicity
band (Fig. 6 A), indicating covalent dimerization with a
partner of  27 kD. To investigate whether KLRE1 inter-
acts with SHP-1 directly, 293T cells were cotransfected
with KLRE1-HA and rat SHP-1 expression constructs.
After pervanadate stimulation, whole cell lysates were
immunoprecipitated with anti–SHP-1 or with anti-HA
antibodies. In this situation, KLRE1-HA could not be
coprecipitated with SHP-1, or vice versa (unpublished
data), suggesting that the SHP-1 binding observed with the
dimeric form of KLRE1 is mediated by an as yet unidenti-
Figure 4. KLRE1 can be expressed as a dimer in the NK cell mem-
brane. The IL-2–dependent RNKDA1 cell line was stably transfected with
a KLRE1-HA expression construct. (A) RNKDA1–tx cells express
KLRE1-HA in the cell surface as demonstrated by flow cytometry. Un-
transfected cells are shown for comparison. (B) Whole cell lysate of 293T
cells transiently transfected with the KLRE1-HA expression construct
(293T-tx) was separated by SDS-PAGE under nonreducing (NR) and re-
ducing (R) conditions and analyzed by Western blotting using anti-HA
mAb. (C) The RNKDA1 NK cell line was stably transfected with a
KLRE1-HA expression construct (RNKDA1-tx), lysed in Triton X-114
buffer, and the membrane protein fraction was separated by SDS-PAGE,
blotted, and probed with anti-HA mAb or (D) the anti-KLRE1 mAb
WEN27. (E) Triton X-114 lysate of IL-2 activated DA NK cells was sep-
arated by SDS-PAGE and analyzed by Western blotting using the
WEN27 mAb.
Figure 5. KLRE1 inhibits NK cytotoxicity. 4 h chromium release re-
directed lysis assay with IL-2–activated DA NK cells as effector cells.
Labeled target cells are denoted above each graph, and effector:target
cell ratio denoted below the graphs. The effector cells were preincubated
with control mAb, WEN27 whole Ig or WEN27 F(ab )2 as indicated.
Figure 6. KLRE1 is associated with SHP-1. Freshly isolated NK cells from
DA rats (DA NK) and RNKDA1 cells transfected with a KLRE1-HA expres-
sion construct (RNKDA1-tx) were analyzed by immunoprecipitation with
anti-SHP-1 ( SHP-1) (A) or anti-HA antibody (HA.11) (B). (A) Pervana-
date stimulated (5 min at 37 C) ( ) and unstimulated ( ) cells were lysed in
1% digitonin buffer and immunoprecipitated with  SHP-1. The immune
complexes were separated by SDS-PAGE under nonreducing (NR) and re-
ducing (R) conditions respectively, blotted onto a membrane, and probed
with WEN27 or anti-HA antiserum. Equal amounts of immunoprecipitated
SHP-1 were verified by Western blotting using anti–SHP-1 antibodies (un-
published data). (B) Western blots of HA.11 immunoprecipitates from per-
vanadate stimulated cells probed with  SHP-1. The right lane with whole
cell lysate (WCL) shows the position of SHP-1 ( 70 kD). The  50 kD
band in the HA.11 immunoprecipitate lanes represents the Ig heavy chain of
the anti-HA antibodies (SDS-PAGE performed under reducing conditions).T
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fied partner chain expressed in IL-2–activated NK cells, but
lacking in 293T cells.
Discussion
The sequence similarities, selective transcription by NK
cells, genetic localization to the NKC, and a simple pattern
on genomic Southern blots constitute evidence that the
cloned cDNA molecules belong to a novel single-gene
KLR family, and represent orthologs in the mouse and the
rat. Attempts to clone a human ortholog by low stringency
hybridization to a human NK cell cDNA library failed, and
searching the genome, EST and htgs databases revealed no
human counterpart. Two splice variants differing in posi-
tion of the cytoplasmic, NH2-terminal start codon were
found in the rat. In the mouse, the short splice variant was
not detected, probably reflecting a T→G transversion at
position –10 in the upstream pyrimidine tract of the puta-
tive second splice site, consistent with the lack of an in-
frame ATG following this site.
As the protein lacked cytoplasmic ITIMs as well as a
charged amino acid in the TM domain, the deduced amino
acid sequence gave no indication as to whether KLRE1
would transmit activating or inhibitory signals. Two obser-
vations indicate an inhibitory role. First, in the redirected
lysis assay, adding whole Ig WEN27 mAb to the culture
medium inhibited lysis of NK sensitive Fc receptor positive
tumor target cells, whereas addition of WEN27 F(ab )2
fragments did not. Second, SHP-1 could be precipitated
with KLRE1 from lysates of pervanadate treated DA NK
cells. So far SHP-1 is only known to associate with KLRs
via the binding of its tandem SH2 domains to phosphory-
lated ITIMs (11–16, 21). Although mouse and rat KLRE1
lack ITIMs, the KLRE1 polypeptide contains a tyrosine
residue in the intracellular region that could be subject to
phosphorylation, and might form part of an as yet unidenti-
fied motif involved in binding SHP-1. However, KLRE1
could not be coimmunoprecipitated with SHP-1 from ly-
sates of pervanadate treated 293T cells cotransfected with
rat SHP-1 and KLRE1.
At the start of the lectin domain most KLR molecules
contain two conserved cysteines that have been shown to
form a disulphide bridge, creating a loop that probably
functions to stabilize the base of the lectin domain (44–47).
These cysteines are also present in KLRE1 (Cys113 and
Cys 124 in the mouse and the long rat splice variant), prob-
ably contributing to loop-formation. Within this presumed
loop both rat and mouse KLRE1 contain an extra cysteine
(Cys 112, marked with a diamond in Fig. 1 A). As there are
no other membrane external cysteines that could partici-
pate in intrachain disulphide bonding, Cys112 represents a
candidate for inter-chain disulphide bonding. The fact that
KLRE1 can form covalently linked dimers was shown by
transient transfection of 293T cells and by stable transfec-
tion of a DA NK cell line (RNKDA1) with the KLRE1-HA
expression construct. In both systems Western blot analysis
performed under nonreducing conditions showed a band
corresponding to  54 kD, using anti-HA antibodies,
WEN27, or a polyclonal antipeptide antiserum. We would
therefore expect that native KLRE1 also formed homo- or
heterodimers in untransfected cells, as is the case for the
other KLRs investigated. Surprisingly, Western blot analy-
sis of nontransfected DA NK cells showed strong staining
of a  27 kD band, both under nonreducing and reducing
conditions, plus a weaker band corresponding to the ex-
pected dimer under nonreducing conditions. The nature of
the 27 kD band has not been investigated, but may repre-
sent a monomeric or noncovalently linked heterodimeric
form of KLRE1, not necessarily expressed on the cell sur-
face. Nevertheless, when KLRE1 was coimmunoprecipi-
tated with antibody against SHP-1 from digitonin lysates
of pervanadate-treated DA NK cells, a strong  54 kD
KLRE1 band was obtained, suggesting that the dimeric
form of KLRE1 is the functionally active, inhibitory form
of the receptor. An analogous type of receptor is the
CD94/NKG2A heterodimer, that recruits SHP-1 through
two tandem ITIM motifs in the cytoplasmic region of
NKG2A, whereas the CD94 chain appears to lack a direct
signaling function (19–21). Sequence comparison showed
that KLRE1 is more closely related to CD94 than to other
KLR families. After cotransfection of 293T cells with
rKLRE1-HA and rNKG2A-FLAG expression constructs,
the two chains could not be coprecipitated with either
anti-HA or anti-FLAG antibodies (unpublished data). To-
gether, the presented data indicate that KLRE1 may form a
functional heterodimer with an as yet unidentified ITIM-
bearing partner that recruits SHP-1 to generate an inhibi-
tory receptor complex.
These studies indicate the existence of a novel NKC-
encoded C-type lectin-like NK cell receptor in rodents that
may inhibit immune function. Efforts to identify the puta-
tive heterodimeric partner chain are currently proceeding.
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